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RNA-Seq reveals changes in human placental metabolism,
transport and endocrinology across the first–second trimester
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Hamid5, Eric Jauniaux6, D. Stephen Charnock-Jones1,7,8, Graham J. Burton1 and Tereza Cindrova-Davies1,*,‡
ABSTRACT
The human placenta is exposed to major environmental changes
towards the end of the first trimester associated with full onset of the
maternal arterial placental circulation. Changes include a switch from
histotrophic to hemotrophic nutrition, and a threefold rise in the
intraplacental oxygen concentration. We evaluated their impact on
trophoblast development and function using RNA-sequencing (RNA-
Seq) and DNA-methylation analyses performed on the same chorionic
villous samples at 7–8 (n=8) and 13–14 (n=6) weeks of gestation.
Reads were adjusted for fetal sex. Most DEGs were associated with
protein processing in the endoplasmic reticulum (ER), hormone
secretion, transport, extracellular matrix, vasculogenesis, and reactive
oxygen speciesmetabolism. Transcripts higher in the first trimesterwere
associated with synthesis and ERprocessing of peptide hormones, and
glycolytic pathways. Transcripts encoding proteins mediating transport
of oxygen, lipids, protein, glucose, and ions were significantly increased
in the second trimester. Themotifs of CBX3 andBCL6were significantly
overrepresented, indicating the involvement of these transcription factor
networks in the regulation of trophoblast migration, proliferation and
fusion. These findings are consistent with a high level of cell proliferation
and hormone secretion by the early placenta to secure implantation in a
physiological low-oxygen environment.
KEY WORDS: Early placenta, Metabolism, Transcriptome, Human
pregnancy, Methylation
INTRODUCTION
The placenta is essential to a successful pregnancy and the lifelong
health of the offspring. Impaired placental function has both
immediate obstetric consequences (Brosens et al., 2011), including
miscarriage, fetal growth restriction, pre-eclampsia and stillbirth,
and long-term impact on the risk of chronic disease for the offspring
(Burton et al., 2016). Recent advances in imaging and biomarker
studies indicate that the pathophysiology of many non-
communicable complications of pregnancy starts during early
pregnancy (Smith, 2010). The human gestational sac from which
the placenta and fetus develop undergoes a major transition towards
the end of the first trimester with the switch from histotrophic to
hemotrophic nutrition (Burton et al., 2010). This transition, which
involves the same placental structure being supported by contrasting
nutrient pathways, is unique to humans and great apes, and may
explain why conditions such as pre-eclampsia are virtually restricted
to the human.
During the first trimester, maternal arterial blood flow into the
placenta is restricted by aggregates of endovascular trophoblast that
migrate down the lumens of the endometrial spiral arteries (Turco
and Moffett, 2019). Consequently, the placental tissues develop in a
relatively low-oxygen environment (Jauniaux et al., 2000),
supported principally by carbohydrate- and lipid-rich secretions
from the endometrial glands (Burton et al., 2002). These secretions
are also a potential source of mitogenic growth factors, including
epidermal growth factor that stimulates proliferation of
cytotrophoblast cells when applied to explant cultures (Burton
et al., 2020; Maruo et al., 1992). Metabolism of the placental tissues
is heavily glycolytic, supported by high activity in polyol metabolic
pathways (Burton et al., 2017).
Towards the end of the first trimester, the endovascular
aggregates canalise, which, along with coordinated remodelling of
the arcuate and radial arteries (Allerkamp et al., 2020), allows full
onset of the maternal circulation as confirmed by a threefold rise in
the intraplacental oxygen concentration (Jauniaux et al., 2000). The
rise is thought to induce maturational changes, including villous
regression to form the definitive placenta and the membranes
(Jauniaux et al., 2003b). Oxygen has also been implicated in the
regulation of trophoblast proliferation and invasion, hormone
production and transporter expression, based largely on in vitro
data (Caniggia et al., 2000; Graham et al., 2000; Pringle et al.,
2010). The transition from histotrophic to hemotrophic nutrition
involves other potential influences, however, such as the dilution of
growth factor support and increased biomechanical forces,
including shear stress, at the villous surface. Previous studies have
compared gene expression in the first trimester placenta with that of
term placentas using microarray analysis (Mikheev et al., 2008;
Sitras et al., 2012). In order to address the critical changes taking
place during the first–second trimester transition, we performed
RNA-Seq and array-based DNA methylation profiling on the same
samples of placental villous tissue, obtained from accurately dated
and narrowwindows of gestation: 7–8 weeks and 13–14 weeks. TheReceived 27 November 2020; Accepted 9 April 2021
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samples were obtained under optimal conditions using an
ultrasound-guided chorionic villous sampling (CVS) technique
that avoided the stress induced by curettage (Cindrova-Davies et al.,
2015). We focussed our analyses on transcripts encoding proteins
involved in metabolism, hormone synthesis, transport and cell
proliferation. We also discuss transcripts with both differential
expression and differentially methylated regions found in their
promoters and gene-bodies.
RESULTS
Samples separated clearly on the basis of gestational age with both
principal component analysis (PCA) and hierarchical clustering
(Fig. 1A; Fig. S1). Differential expression analysis identified 3260
differentially expressed genes (DEG) (adjusted P-value,
Padj. ≤0.05, absolute fold change ≥2; Fig. 1B; Table S1). In
view of the sex bias in the sample groups (Fig. 1A), we performed a
sex-adjustment analysis. Sex was confirmed using sex-specific
genes, Xist, Rps4y1, Ddx3y, Usp9y and Sry, and was included in the
design formula (∼sex+condition) as a blocking factor to account for
variation in the data.
Using Kegg pathway analysis and Gene Ontology analysis (GO),
we identified several classes of genes that change simultaneously
between the first and second trimesters (Fig. 1C–F; Tables S2-5).
Notably, genes associated with protein processing in the
endoplasmic reticulum (ER) were amongst the most differentially
expressed, as were genes regulating cellular metabolism, hormone
secretion, transport and the extracellular matrix (Fig. 1C–F).
Changes for selected transcripts were validated at the protein
level, using either western blotting or immunohistochemistry. To
ascribe the DEGs to individual cell types the RNA-Seq results were
compared with a published scRNA-Seq dataset (Liu et al., 2018)
that included first-trimester (8 weeks) and late-second-trimester
(24 weeks) samples. The scRNA-Seq identified several cell types in
8-week placentas, including cytotrophoblast (CTB),
syncytiotrophoblast (STB), extravillous trophoblast (EVT) and
stromal cells (STR), and EVT in 24-week placentas.
Metabolism
Analysis of GO and Kegg pathway enrichment showed that genes
associated with protein processing in the ER to be amongst the most
differentially expressed between the two time points. The Kegg
pathway ‘protein processing in ER’ was enriched in the first
trimester (Padj.=1.63×10−3; Fig. S2), as were the GO terms ‘protein
folding in ER’ (Padj.=6.31×10−3) and ‘regulation of protein
secretion’ (Padj.=3.70×10−8; Fig. 1C–F). These, and other related
GO terms suggest that ER functional activity is greater during the
first than the second trimester, despite the relatively low oxygen
concentration prevailing.
The transcript profile observed provides further evidence that
placental tissues are not energetically compromised during the first
trimester. Glycolysis is the primary route to energy generation,
supported by the polyol pathways that preserve carbon skeletons for
synthesis of purines and other molecules required for rapid cell
proliferation (Burton et al., 2017). Consistent with this metabolic
profile is the finding that PKLR and HK2, which encode the
principal regulators of glycolysis, pyruvate kinase and hexokinase,
are among the most differentially expressed genes (Fig. 2A–B).
Pyruvate kinase is a key enzyme of the glycolytic pathway that
catalyses the production of pyruvate and ATP from
phosphoenolpyruvate. The synthesis of pyruvate kinase is
controlled by two structural genes, the L-type gene (coding for
the L and R isozymes) and the M-type gene (coding for the M1 and
M2 isozymes), and four different mRNAs control the synthesis of
pyruvate kinase isozymes. We detected a 5.3-fold change decrease
in PKLR expression in the second trimester (Fig. 2A). The enzyme
primarily localized to the syncytiotrophoblast of the first trimester
villi (Fig. 2B). These findings are in agreement with those of
Diamant et al. (1975) who reported elevated activity of pyruvate
kinase in early gestation, indicative of high glycolytic potential,
which tended to decrease with increasing gestational age.
Whilst present at low levels in most normal adult cells, HK2 is
highly expressed in embryonic tissues and cancer cells (Patra and
Hay, 2013). Germ line deletion of Hk2 in the mouse causes
embryonic lethality (Heikkinen et al., 1999). We found HK2
expression to be significantly higher in the first trimester, with a
switch to theHK3 isoform during the second trimester. HK2 follows
Michaelis–Menten kinetics. It has low Km values for glucose,
allowing for HK2 to be sensitive to accumulation of glucose-6
phosphate. In contrast, HK3 is inhibited by excess glucose and its
substrate binding is attenuated by intracellular ATP (Cardenas et al.,
1998).
Our data thus support the notion that glycolysis is replaced by
oxidative mitochondrial respiration as the primary method of energy
generation after the first trimester. Indeed, this conclusion is
underpinned by the upregulation of the transcriptional co-repressor,
CBFA2T3, at 13–14 weeks, which contributes to inhibition of
glycolysis and stimulation of mitochondrial respiration (Kumar
et al., 2013). Conversely, β-oxidation of fatty acids appears
suppressed in the first trimester. Transcripts encoding long-chain
acyl-CoA dehydrogenase (ACADL) rise in the second trimester
(Fig. 2A). These changes may serve to protect the placental tissues
from excessive production of reactive oxygen species when oxygen
availability is low (Burton et al., 2017; Huang et al., 2014).
The ER is responsible for synthesis and post-translational
modification of secreted and membrane proteins, and for
intracellular Ca2+ storage. Loss of homeostasis activates the unfolded
protein response (UPR), which is mediated by three signalling
transducers: IRE-1 (inositol-requiring transmembrane kinase-
endoribonuclease 1), PERK (PKR-like endoplasmic reticulum
kinase) and ATF6 (activating transcription factor 6). Activity of
these transducers is inhibited in the physiological state by binding of
the ER chaperone protein BiP/GRP78/HSPA5. Transcripts encoding
the sensor IRE1, known as ERN1 (Fig. 2C), and its downstreamX-box
binding protein 1 (XBP1) were significantly higher in the first trimester
(Fig. 2C–E), with no quantitative change in GRP78 RNA or protein
expression (Fig. 2F). There was no quantitative change in ATF6 RNA
expression but a subtle change in protein cellular localisation, as ATF6
immunostaining was observed almost exclusively in the
cytotrophoblast cell columns during the first trimester, whilst it was
localised less in the diminishing cell columns and more in the
mesenchymal cells and syncytiotrophoblast in the second trimester
(Fig. 2E). We also report a modest increase in PERK (EIF2AK3)
(Fig. 2C; Fig. S2). In addition, transcripts encoding several heat shock
proteins (DNAJB9, DNAJB11, DNAJC3, HSPA5 and HSP90B1),
those involved in protein post-translational modifications (LMAN1,
MAN1C1, MAN1A2, PDIA6, PDIA3 and ERO1A) and protein quality
control (ERP44, HERPUD1 and EDEM2), were also higher in the first
trimester (Fig. 2C). These are likely to be homeostatic responses to a
high synthetic activity.
Heat-shock proteins perform chaperone functions by stabilising
new polypeptides, while PDIAs, ERO1A and MAN1s assist in
disulphide bond formation and glycosylation to ensure correct
folding of proteins. Activation of IRE-1 and its downstream target
XBP1 are involved in the synthesis of lipoproteins essential for cell
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and organelle membranes. However, the actions of these pathways
may be broader than just ER homeostasis. Activation of the IRE-1
pathway has been observed during development of the labyrinth
zone of the murine placenta, with knockout of the gene leading to
abnormal vascularisation (Iwawaki et al., 2009). We confirmed
activation of the IRE-1/XBP1 pathway during the first trimester by
Fig. 1. RNA-Seq identification of DEGs, functions and pathways distinct to first and second trimester placentas. (A) PCA separation of first and
second trimester samples. (B) Volcano plot of DEGs, with genes higher in the first trimester in red, and those higher in the second trimester in blue.
(C) Selected Kegg pathways, which were differentially regulated during the first and second trimester. (D–F) Barplots showing selected differentially regulated
GO terms related to biological processes (D), molecular functions (E) and cellular components (F). Each barplot shows how many genes within each term
are expressed more in the first (red) or second trimester (blue). Transparency is used to show the most significant (Padj.) terms as least transparent. Terms
were ordered by q-value.
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Fig. 2. See next page for legend.
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immunostaining. XBP1 was strongly expressed by the villous and
extravillous trophoblast of the cell columns, and XBP1 expression
coincided with that of IRE-1 and P-IRE-1 (Fig. 2E).
As expected, there was upregulation of genes associated with
oxidative stress and antioxidant defences during the second
trimester, most notably SOD3, HIF3A, COX4I2, CYP1A1,
CYP1A2 and NOS1AP (Fig. 2G), in agreement with our previous
findings (Jauniaux et al., 2000). Several GO terms associated with
metabolism of oxygen were also significantly different between the
gestational ages, including ‘reactive oxygen species metabolic
process’ and ‘reactive oxygen species biosynthetic process’ (see
Tables S3–S5). Consistent with these terms, we observed increased
phosphorylation of eIF2α in the second trimester, indicative of
activation of the UPR (Fig. 2F).
Hormonal activity
Transcripts encoding peptide hormones showed considerable
differential expression (Fig. 3A,B). Transcripts higher at 7–
8 weeks included subunits of hCG; CGA showed a 3.79-fold
change while CGB1, CGB2, CGB3, CGB5, CGB7 and CGB8
showed fold changes of 3.68, 6.69, 3.84, 3.87, 4.94 and 3.59,
respectively. These results confirmed previous findings that all six
hCG genes are transcribed (Bo and Boime, 1992), and are consistent
with secretion of hCG peaking at around 10 weeks of gestation.
Secretion is likely to be stimulated by the epidermal growth factor
receptor (EGFR) pathway (Wang et al., 2018). EGF is produced by
the endometrial glands (histotroph pathway), and this signalling
loop may be part of the trophoblast–endometrial dialogue
stimulating early placental development (Burton et al., 2020).
Also higher in the first trimester were transcripts encoding leptin
(LEP) (fold change 3.16, Fig. 3A,B), relaxin (RLN1) (fold change
2.82) and insulin-like-4 (INSL4) (fold change 3.15). Comparisons
with the scRNA-Seq data indicated the transcripts were enriched in
the syncytiotrophoblast (Fig. 3A), the known site of production of
hCG (Beck et al., 1986).
The greatest change in transcripts upregulated in the second
trimester was for spexin (SPX) (fold change 11.08) (Fig. 3A,C).
Immunostaining showed the hormone to be localised to the
syncytiotrophoblast (Fig. 3C). The hypocretin receptor 2
(HCRTR2), also known as orexin receptor 2, is another pathway
regulating appetite and lipid metabolism (Burdakov and
Alexopoulos, 2005), and we found that its mRNA increased 8.55-
fold between the first and second trimesters (Fig. 3A). In contrast,
the transcript and protein levels of the hunger and satiety-
maintaining hormone leptin were significantly higher in the first
trimester placenta (Fig. 3A,B). Leptin concentrations are elevated
during pregnancy due to an accumulation of maternal body fat and
placental production. However, in contrast to leptin’s effect on
satiety, pregnancy requires increased food intake to meet the
nutrient demands of the fetus and to lay down fat stores that are
mobilised during late gestation and lactation. This apparent paradox
is resolved by the development of central leptin resistance, which
occurs in the second trimester of pregnancy (Grattan et al., 2007).
Leptin mRNA and protein were found to colocalise to the
syncytiotrophoblast and fetal endothelial cells in human placentas,
suggesting that the placenta is a source of both fetal and maternal
leptin (Lea et al., 2000).
Kegg pathway analysis showed that transcripts associated with
‘autoimmune thyroid disease’ and ‘parathyroid hormone synthesis,
secretion and action’ were differentially expressed across the
transition (Fig. 1C; Table S2). Thyroid hormones are important
for early fetal development, in particular for the central nervous
system, and must be transported across the placenta (Chan et al.,
2009). Three major binding proteins, T4 binding globulin,
transthyretin and albumin have been identified in the mature
placenta (McKinnon et al., 2005). Here, we show for the first time
that transcripts of CRYM, which encodes crystalline mu, a T3
binding protein, are present in the placenta and highest during the
first trimester (2.97-fold change). By contrast, TTR encoding
transthyretin is more highly expressed in the second trimester (2.9-
fold change) (Fig. 3A,B). These findings suggest novel regulatory
pathways for the transfer of thyroid hormones across the placenta,
which change as pregnancy progresses.
Transport
Transcripts encoding proteins mediating oxygen, lipid, protein,
glucose and ion transport changed significantly (Fig. 3D,E).
Transcripts encoding the hemoglobin subunits epsilon 1 and zeta
(HBE1 and HBZ) were within the top three differentially expressed
genes, and were 43.16- and 42.47-fold lower in the second-trimester
samples (Fig. 3D,E). HBE1 and HBZ make up embryonic
hemoglobin that predominates during the first trimester.
Conversely, the mRNA for hemoglobin G2 and hemoglobin beta
(HBG2 and HBB) were 2.98- and 3.49-fold higher in the later
samples. HBB is a component of adult haemoglobin, while HBG2 is
a component of fetal hemoglobin that is present at birth. These
transcripts are likely to arise from the hemangioblastic clusters
within the villous stromal core (Aplin et al., 2015), but both
embryonic and fetal hemoglobin transcripts have been identified
within purified CTB and EVT cells (Apps et al., 2011). Whether the
changes in expression are determined by the rise in oxygen
concentration, possibly protecting against oxidative stress (Nishi
et al., 2008; Saha et al., 2014), or are ontogenetic is not known.
The pattern of expression of lipid transporters and
apolipoproteins was profoundly different between the two
trimesters. Transcripts highly abundant during the first trimester
included APOA2 and ABCB11, whereas those upregulated in the
second trimester included ABCA6, ABCC8 and APOD (Fig. 3E,
Fig. S3). ApoD protects against ischemia-reperfusion injury in
myocardial infarcts and has potent antioxidant activity, which may
buffer the placenta once the maternal blood flow is established
(Tsukamoto et al., 2013). Cholesterol is essential in early embryonic
metabolism, cell signalling and elaboration of cell and organelle
membranes, and must be transported across the placenta into the
chorionic cavity. From there it is likely transported into the
embryonic circulation via the secondary yolk sac, which expresses
mRNAs encoding multiple apolipoproteins, the cholesterol efflux
Fig. 2. DEGs associated with ER processing, oxidative stress and
glycolytic processes. (A) Heatmap of DEGs involved in the glycolytic
pathway. Top DEGs in the first versus second trimester samples were
compared to a previously published scRNA-Seq dataset (see Materials and
Methods). (B) Immunostaining of first- and second-trimester sections with
anti-pyruvate kinase antibody. (C) Heatmap of top DEGs in the first versus
second trimester samples involved in ER stress and processes. Top DEGs
were compared to a previously published scRNA-Seq dataset (see Materials
and Methods). (D–E) Immunolocalisation of XBP1, ATF6, P-IRE1 and IRE1
in first- and second-trimester placental sections, stained with anti-XBP1,
-ATF6, -IRE1 or P-IRE1 antibodies. Arrows denote cell columns (CC).
(F) Western blots depicting GRP78 and phospho-eIF2α (E) or catalase
(CAT) and glutathione peroxidate (GPX) (F) in first- and second-trimester
placental lysates. Ponceau S (Ponc S) staining was used to normalise
protein loading. Data are expressed as mean±s.d. Comparisons were made
using a two-tailed Student’s t-test. Differences were considered significant at
P≤0.05. (G) Heatmap of top DEGs related to oxidative stress. Scale bars are
25 µm in B and D and 200 µm in E.
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transporter ABCA1, and lipoprotein receptors, including megalin
and cubilin (Cindrova-Davies et al., 2017). At the end of the first
trimester, the chorionic cavity is obliterated by the enlarging
amniotic cavity and the secondary yolk sac degenerates.
Contemporaneously, onset of the maternal and fetal placental
circulations permits transport of cholesterol and lipids across the
Fig. 3. See next page for legend.
6









villous membrane, and our data may reflect this change in the lipid
transport pathway.
Transcripts encoding transporters of metal ions important for
antioxidant defences were also higher in the first compared to the
early second trimester (e.g. SLC30A10, SLC30A2, which had 9.56-
and 3.14-fold changes, respectively). This differential might reflect
higher transport of manganese and zinc ions that are essential
cofactors for the superoxide dismutase enzymes during early
pregnancy (Fig. 3E) in preparation for the rapid rise in pO2. Genes
involved in the transport of iron also changed, in particular LTF that
encodes lactotransferrin and HEPH that encodes hephaestin (3.68-
and 4.07-fold changes, respectively).
Transcripts encoding ion channels, for example SCN1A (31.37-
fold change), MCOLN2 (8.83-fold change), TRPA1 (7.38-fold
change) and SCN7A (3.42-fold change) (Fig. 3E) were among those
most significantly increased in the early second trimester. This may
reflect a switch in the way amino acids are transported across the
placenta. In the first trimester, they are transported by uptake and
subsequent breakdown of proteins in maternal histotroph (Burton
et al., 2002), whereas later in pregnancy there is active uptake of
individual amino acids from the maternal circulation through
accumulative and exchange transporters (Lewis et al., 2013).
Activity of the latter needs to be balanced by other ionic fluxes.
Cell proliferation, differentiation and WNT signalling
Recent evidence suggests that WNT signalling may be implicated in
the regulation of placental development and human trophoblast
differentiation (Haider et al., 2017; Nayeem et al., 2016). Our data
show that RSPO4, WNT10B and several other genes mediating the
canonical WNT signalling, including PORCN and SDC1, were
higher in the first trimester than in the early second trimester
(Fig. 4A). By contrast, WNT3A, WNT10A, WNT2, LRRK2, RYR2,
LRP6, CCND1 and RSPO3 transcripts were significantly
upregulated in the second trimester (Fig. 4A). Canonical WNT
signalling has been shown to be critical for invasive trophoblast
differentiation (Pollheimer et al., 2006). In addition, several genes
that regulate the non-canonical WNT pathway were upregulated in
the second trimester, including WNT5B and LEF1. Negative
regulators of the WNT signalling, NKD2 and DKK3, were also
upregulated in the second trimester, suggesting that paracrine
mechanisms play a role in regulating trophoblast invasion during the
second trimester. The majority of the WNT-signalling transcripts
upregulated in the second trimester were localised to EVT, whilst
transcripts that were higher in the first trimester were localised to
both EVT and the syncytiotrophoblast (Fig. 4A).
Extracellular matrix and angiogenesis
Significant differences were found in transcripts regulating
extracellular matrix (ECM) remodelling (Fig. 4B). In particular,
laminin LAMA1 was highly expressed in the first trimester, whereas
LAMB3, LAMA2, LAMC3 were upregulated in the second trimester.
Laminins have an important role during implantation (Haouzi et al.,
2011), maintenance of trophoblast stemness (Kiyozumi et al., 2020)
and EVT migration (Zhang et al., 2018b).
Shortly after implantation, EVT migrate from the placenta into
the endometrium where they are involved in the remodelling of the
maternal spiral arteries that ultimately supply the placenta. The
invasive properties of these cells are widely attributed to the matrix
metalloproteinases 2 and 9 (Isaka et al., 2003; Staun-Ram et al.,
2004). We found the mRNAs forMMP9 (3.14-fold), MMP1 (7.99-
fold) and MMP28 (3.77-fold) to be upregulated in the second
trimester. MEP1A encodes for meprin, a member of the astacin
family of metalloproteinases that was 2.46-fold higher in the second
trimester. Meprins can be secreted, and thus may assist in matrix
digestion, or be membrane bound, where they may be involved in
extracellular cleavage of proteins (Sterchi et al., 2008). Meprins are
expressed abundantly by epithelial cells of the intestine, kidney and
skin, and we show for the first time that are located in the villous
syncytiotrophoblast (Fig. 4C). We speculate they might be involved
in remodelling the basement membrane during villous growth.
Vasculogenesis and angiogenesis are critical for successful
placental exchange, and it has been suggested that the low-
oxygen conditions during the first trimester stimulate these
processes. However, we did not find classical hypoxia-regulated
factors, such as VEGF, to be differentially expressed. This supports
our previous findings showing that HIF protein is not stabilised
during early pregnancy (Cindrova-Davies et al., 2015). By contrast,
transcripts encoding other potent regulators of angiogenesis,
angiogenin (ANG) and endoglin (ENG), were found to be higher
during the first trimester (5.72- and 3.23-fold changes, respectively,
Fig. 4B). Angiogenin mRNA and protein have been localised in the
trophoblast and endothelial cells of the fetal placental vessels
(Pavlov et al., 2014). In contrast, markers of vascularisation such as
PECAM1 (CD31), VWF, ICAM1 were significantly upregulated in
the second trimester compared to the first trimester (Fig. 4B,D),
indicating that the vascular components of the villi develop rapidly
during the second half of pregnancy.
During pregnancy, the maternal immune system is modulated by
signals from the placenta, with evidence of increased activation of
innate cells in the systemic circulation. Regulatory
CD4+CD25+Foxp3+ T cells (Tregs) expand during the second and
third trimesters in the peripheral blood and in the decidua, believed
to be induced by paternal antigens and contributing to the local
control of fetus-specific maternal immune responses (Kahn and
Baltimore, 2010; Rowe et al., 2012). The transcription factor
musculin (MSC) is critical for the development of induced Treg
cells by repression of the T helper type 2 transcriptional program
(Wu et al., 2017). Transcripts for MSC were significantly
upregulated in the second trimester (Fig. 4B,E). This is the first
demonstration of the presence of this immune-regulator in the
syncytiotrophoblast, although it may have a different function to its
role in Tregs (Fig. 4E).
Transcription factors
Rapid cell proliferation and differentiation occurs during the first
trimester to establish the placenta. Transcripts encoding the
transcriptional regulator high-mobility group AT-hook 2 protein
(HMGA2) were 7.55-fold higher in the first trimester than the
second (Fig. 4F). HMGA2 is known to play a role in proliferation
and differentiation, and homozygous mutations in Hmga2 result in
the pygmy phenotype in mice (Zhou et al., 1995). We found that
expression of HAND1, a transcription factor regulating
Fig. 3. Overview of hormonal and transport-related placental genes
differentially expressed in the first and second trimesters. (A) Heatmap
showing top DEGs related to hormones and compared to the scRNA-Seq
data. (B) Western blots depicting transthyretin (TTR) and leptin levels in first
and second trimester placental lysates. Ponceau S (Ponc S) staining was
used to normalise protein loading. Data are expressed as mean±s.d..
Comparisons were made using a two-tailed Student’s t-test. Differences
were considered significant at P≤0.05. (C) Immunostaining of first and
second trimester sections with anti-spexin antibody. (D) Volcano plot of
transport-related genes, with DEGs coloured red higher in the first trimester,
and those in blue higher in the second trimester. (E) Heatmap of top
transport-related genes, split by type of transport. Scale bars are 25 µm.
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Fig. 4. See next page for legend.
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differentiation of trophoblast subtypes in the mouse (Scott et al.,
2000), was also higher in the first trimester (6.63-fold) (Fig. 4F), but
its function during human placental development is unknown.
Many of the transcription factors upregulated in the second trimester
regulate mammalian development and differentiation processes.
These include KLF2, SOX14, SOX18, LHX6, MEF2C, SOX7,
HEYL, TFAP2E, MYT1, BNC2 and STAT4 (Fig. 4F).
To investigate potential regulatory networks of the placenta, we
performed a motif rankings analysis. DEGs were scanned for the
motifs, and DNAmotifs significantly over-represented in a gene-set
were identified. The CBX3 motif was the only common
transcription factor motif that was significantly overrepresented in
both searches (235 DEGs with CBX3 motif at 500 bp upstream of
TSS and 691 genes with this motif in 10kb-centered around TSS)
(Fig. 4G). We have compared our DEGs enriched with CBX3 motif
with the targetome of CBX3 transcription factor, based on
ENCODE Transcription Factor Target Database (Consortium,
2011; Rouillard et al., 2016). We found that 68 out of 237 DEGs
with CBX3 motif within 500bp-TSS were already identified as
CBX3 targets in that database. Some of the unidentified CBX3-
enriched DEGs may be unique for the placenta, as many TF binding
patterns are tissue-type specific.
The CBX3 gene was slightly downregulated in the second
trimester (-1.28-fold change, Padj. 0.0029). CBX3 plays a role in
transcriptional silencing in heterochromatin-like complexes, and
may contribute to the association of the heterochromatin with the
inner nuclear membrane through its interaction with lamin B
receptor. In mice, Cbx3 inhibits vascular smooth muscle cell
proliferation, migration, and neointima formation (Zhang et al.,
2018a). DEGs with the CBX3 motif (500bp-TSS) were extracted
and pathway analysis with enrichR was performed. The top
enriched term for WikiPathways_2019 and Kegg_2019 was ‘Wnt
Signaling’ (Padj. 0.00049 and 2.794813e-03, respectively)
(Fig. 4G), while the term ‘ion channels and their functional role
in vascular endothelium’ (Padj.=0.042; Fig. 4G) was enriched from
BioCarta_2016. These findings indicate that CBX3 could be the
transcription factor, which links at least some of the differential
changes taking place in the two trimesters, such as the differential
regulation of the WNT signalling pathway that mediates EVT
migration and trophoblast function, endothelial function and ion
channel transport.
In addition to the CBX3 motifs and transcription networks, the
motif for BCL6 was significantly overrepresented within 10 kb
around TSS of DEGs (lower confidence motifs). The pathway
analysis for DEGs enriched in BCL6 motif has shown similar terms
to these for CBX3, i.e. ‘ion channels and their functional role in
vascular endothelium’ from BioCarta (Padj. 0.0026) and ‘vascular
smooth muscle contraction’ (Padj. 0.00765) from Kegg (Fig. S4).
The BCL6 expression is significantly lower in the second trimester
(-2.175-fold change, Padj. 0.018) and it has been previously shown
to be required for proliferation of villous cytotrophoblast cells
(Muschol-Steinmetz et al., 2016), whilst BCL6 overexpression
reduces trophoblast fusion and is increased in pre-eclamptic
placentas (Jasmer et al., 2017).
DNA Methylation
Placental DNA methylation increases over gestation, and in-utero
exposures alter methylation and impact placental function and fetal
health (Vlahos et al., 2019). Previous studies have compared first
and second trimester methylation; however, these studies were not
designed specifically to study the impact of onset of the maternal
circulation inside the placenta. Thus, Novakovic et al. compared 8–
12 week versus 17–24 weeks samples using a 27K methylation
array focusing on gene promoters, but the first trimester samples
overlap the first-second trimester transition (Novakovic et al.,
2011). Nordor et al. compared 8–10 week to 12–14 week samples
using a 450K methylation array, with the later time points
overlapping the onset of maternal blood flow (Nordor et al.,
2017). In both studies, gene expression data were not taken from the
same samples, and standard bisulfite-treatment was used, which
also includes a confounding 5-hydroxymethylcytosine (hmC)
signal. In the present study, we extracted DNA from the same
patient samples that we used for the RNA-Seq analysis. We have
used an oxidative bisulfite treatment on samples assaying only 5-
methylcytosine (mC). We also performed the methylation analysis
using an EPIC array assaying over 850 K CpG sites with higher
coverage to previous studies. Our study is therefore uniquely placed
to elucidate the gene expression and methylation differences
immediately before and after the full onset of maternal blood flow
on the same samples (see Fig. 5A for a comparison of related
datasets). Sex-specific effects were removed (see Materials and
Methods).
Samples clustered separately by gestational age in a PCA using
the most variably methylated CpG positions (n=500) (Fig. 5B).
Mean CpG methylation across all positions assayed showed that
there is a globally higher level of methylation during the second
trimester (Fig. 5C). Previous studies have indicated the importance
of promoter methylation (Novakovic et al., 2011; Nordor et al.,
2017) and its positive correlation with gestational age. Our study
compared the first and second trimester methylation levels across
specific genomic features associated with gene regulation:
promoters (2 kb upstream of TSS), gene bodies and CpG Islands.
We found the largest difference within gene bodies (Fig. 5D).
Differential methylation analysis between the first- and second-
trimester samples revealed 329 DMRs, with 233 overlapping at least
one gene promoter/body. We then correlated the differentially
expressed genes from the RNA-Seq with differentially methylated
CpGs in the same first- and second-trimester samples. After
applying minimum thresholds of a twofold change (log2 fold
change 1) for gene expression and a 20%methylation difference for
DMRs, we found 49 DMRs overlapped DEGs. In the majority
(36/49), increased gene expression was associated with a
corresponding decrease in methylation at the promoter/gene body.
Overall, a correlation of increased methylation with decreased
expression was observed (R2 0.04, Pearson’s correlation coefficient
P=0.0025) (Fig. 5D; Table S6). For example, increased WNT2
expression correlated with reduced methylation in the second
trimester (Fig. 5D), and may reflect the important role of canonical
WNT signalling for the differentiation of invasive EVT (Pollheimer
et al., 2006).
A GO term analysis suggests the differentially methylated
genes are enriched (Padj.< 0.05) for molecular function terms
related to in transcriptional regulation (Table S7). The GO
analysis for biological processes are enriched for terms associated
Fig. 4. Overview of DEGs related to transcription factors, WNT
signalling and extracellular matrix related genes, differentially
expressed between the first and second trimester. (A) Heatmap of DEGs
associated with WNT signalling. (B) Heatmap of extracellular matrix and
angiogenesis-related DEGs. (C–E) Immunolocalisation of meprin (D), CD31
(E) and musculin (MSC) (F) in first- and second-trimester placental sections
(n=4). Scale bars are 25 µm in C and E and 50 µm in D. (F) Heatmap of
differentially expressed transcription factors. (G) CBX3 motif is enriched in
proportion of DEGs: sequence motif for CBX3, incidence matrix of highly
ranked DEGs with CBX3 motif, and their pathway enrichment analysis.
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with cell fate commitment/specification, embryonic development/
morphogenesis, regulation of metabolic processes and regulation of
transcription (Table S8).
In the first trimester samples, reduced methylation correlated with
higher expression of transcripts encoding the EGFR ligand,
epiregulin (EREG), and EREG expression decreased after the full
onset of maternal blood flow. EGF is abundantly secreted from the
endometrial glands in early gestation when it stimulates
cytotrophoblast proliferation and maintains their stemness
(Burton, 2018; Maruo et al., 1992). Epiregulin promotes the
Fig. 5. DNA methylation changes in first versus second trimester. (A) Comparison of gestational ages between this and related studies. (B) PCA shows
clear separation between the first and second trimesters. (C) Global methylation levels are higher in the second trimester as indicated by a shift in points
towards the top left. Methylation difference thresholds of 0.2 (20%) and 0.4 (40%) (dashed lines). At specific genomic features, the largest difference is
observed at gene bodies with higher methylation during the second trimester, with increased numbers of probes with a methylation difference of over 0.2
(dashed lines). (D) Comparing RNA expression and DNA methylation at promoters and gene bodies shows correlation of reduced expression with increased
methylation from first to second trimester for 36 genes (purple). Thresholds of log2 onefold change and a methylation difference of 0.75 (red line).
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cytotrophoblast-EVT transition through O-fucosylation on
urokinase-type plasminogen catalysed by protein O-
fucosyltransferase 1 (poFUT1) (Cui et al., 2019). This role seems
critical for the pregnancy viability as both epiregulin and poFUT1
were reduced in placentas of patients suffering early pregnancy
failure (Cui et al., 2019).
By contrast, expression of CYP2R1 and RBP7 was increased in
the second trimester, with a corresponding decrease in methylation
at this time. These genes regulate vitamin D and A metabolism;
CYP2R1 converts vitamin D into its active form, whilst RBP7
affects vitamin A stability and metabolism. Adequate vitamin D
function is essential for fetal skeletal development, tooth enamel
formation and general fetal growth and development (Brooke et al.,
1980), and vitamin A (retinoic acid) is essential for the development
of heart, embryonal circulatory and central nervous systems and the
regulation of heart asymmetry (Zile, 1998).
Decreased methylation levels were also correlated with the
upregulation of genes activated in response to oxidative stress in the
second trimester (FAS, WFDC1, AOX1, CH25H). Transcripts
encoding several transporters mediating the uptake of sodium/
potassium (SLC24A4), choline and thiamine pyrophosphate (B1
homeostasis; SLC44A4), organic anions and bile acids (ABCC3),
and drugs (ABCC9) were increased in the second trimester, whereas
magnesium and zinc transporter SLC39A8were increased in the first
trimester. Methylation levels were differentially regulated in all
these genes.
The inverse correlation of DNA methylation with expression
suggests an association for a subset of genes in response to the onset
of blood flow. GO pathways in this subset of genes include signal
transduction, anatomical structure development, cellular protein
modification process, cell differentiation, small molecule metabolic
process, response to stress, transport and immune system process
(Table S8). We further extended the GO analysis to cluster related
significant GO terms by their semantic similarity (Fig. 6) for a
global view of biological processes changing between the first and
second trimesters. Several clusters emerged related to
transmembrane transporters, cell differentiation and development,
and leukocyte and adaptive immune response, highlighting the key
transcriptomic changes during the onset of maternal blood flow.
Interestingly, there was an overlap between the CBX3 targets and
the differentially methylated regions of 22 genes, including WNT2,
EREG, ABCC3, TLL1 and LY75 (Fig. S5). These findings elude to
the potential role of CBX3 in transcriptional silencing of some of its
targets.
DISCUSSION
We sought to examine the effects of changes in the intrauterine
environment that occur across the first–second trimester transition
on the placenta at the levels of the transcriptome and methylome.
The major changes centre around the onset of maternal arterial
circulation, with the switch from histotrophic to hemotrophic
nutrition. They include a threefold rise in oxygen concentration,
together with increases in shear stress and other biomechanical
stimuli at the villous surface. These constitute an environmental
stress to which the placenta must successfully adapt (Jauniaux et al.,
2000).
Our data reveal that expression of transcripts involved in the
synthesis and ER processing of peptide hormones, including hCG,
is high during the first trimester. These findings may initially appear
paradoxical since protein synthesis is energy demanding; however,
despite the initial low-oxygen environment there are no significant
differences in placental concentrations of the main energy
metabolites (ATP/ADP, NAD+, glucose and lactate) across
gestation (Cindrova-Davies et al., 2015). This constancy is due to
high activity of glycolytic pathways during the first trimester, as
shown by the transcriptome profile here and supported by a plentiful
supply of glycogen in the histotroph from the endometrial glands
(Burton et al., 2017). A high output of hCG by the
syncytiotrophoblast soon after implantation is essential to
maintain the corpus luteum and prevent onset of the next menses.
There is also a need for rapid cell proliferation to anchor the
developing placenta into the uterine wall.
The corpus luteum is the principal source of progesterone and
oestrogen until the syncytiotrophoblast takes over (Aspillaga et al.,
1983). We found that the transcripts for two enzymes catalysing the
conversion of cholesterol to progesterone (via pregnenolone),
CYP11A1 (P450scc) or CYP17A1, did not change significantly
between the first and second trimesters. By contrast, the gene
encoding cholesterol 25-hydroxylase (CH25H), which converts
cholesterol to 25-hydroxycholesterol (25OHC), was significantly
upregulated in the second trimester (Figs 2G and 3A), and appears
regulated through methylation (Fig. 5D). 25OHC and other
oxysterols are substrates of P450scc, and 25OHC enhances the
production of steroids by the ovary and testis (Risbridger et al.,
1986; Toaff et al., 1982). Increased expression of CH25H may
contribute to the rise in placental progesterone synthesis at the end
of the first trimester, which is pivotal to maintain the pregnancy.
The transcript pattern encoding proteins mediating transport of
oxygen, lipid, protein, glucose, and ions changed significantly
between the first and early second trimesters, reflecting increased
oxidative stress and the onset of hemotrophic exchange between the
maternal and fetal circulations. There were also increases in
transcripts encoding steroidogenic enzymes, consistent with the
placenta taking over from the corpus luteum, and in transcripts
driving differentiation of the invasive extravillous trophoblast cells
that anchor the placenta and are involved in remodelling of the spiral
arteries that ultimately supply the placenta.
We identified the hormone spexin for the first time in the
syncytiotrophoblast, and found it to be upregulated in the second
trimester. Spexin is involved in the regulation of body weight and
metabolism, and inhibits the uptake of long-chain fatty acids by
adipocytes and hepatocytes (Kolodziejski et al., 2018). Synthesis of
spexin by the villous trophoblast suggests that this protein may play
a role in regulating maternal lipid metabolism during pregnancy,
possibly making more fatty acids available for transport to the fetus.
A recent study measured circulating spexin (SPX) during the course
of pregnancy in women with gestational diabetes mellitus (GDM)
versus healthy controls (Al-Daghri et al., 2019). The study does not
provide direct comparison with ours, as the starting measurements
were taken at 10.3 (±4.9) weeks and thus spanned both the first and
second trimesters. However, the authors reported a significant
increase in circulating levels of spexin in patients who developed
GDM, with values correlating positively with glucose levels.
Hence, placental spexin may influence maternal glucose use and
availability during pregnancy.
Our finding that transcripts encoding the hypocretin receptor 2
are also increased during the second trimester suggests the placenta
may play an important role in modulating maternal appetite and
energy intake during pregnancy. An inverse correlation between
circulating spexin and leptin levels was reported in adolescents with
obesity (Kumar et al., 2018). Leptin mRNA and protein have been
found to colocalise to the syncytiotrophoblast and fetal endothelial
cells in human placentas, suggesting that the placenta is a source of
both fetal and maternal leptin (Lea et al., 2000). In addition, human
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fetal adipose tissue is capable of producing leptin at the beginning of
lipogenesis and differentiation (Atanassova and Popova, 2000).
Placental leptin is transported bidirectionally at both fetal and
maternal interfaces (Hoggard et al., 2001; Wyrwoll et al., 2005).
Leptin may play other roles, for its receptor is expressed on invading
extravillous trophoblast cells, and addition of leptin to
cytotrophoblast cells in culture increases the production of matrix
metalloproteinases (Castellucci et al., 2000). Hence, the hormone
may stimulate trophoblast invasion, particularly during the first
trimester. In addition, leptin is involved in the development and
maturation of a number of organs, including the heart, brain,
kidneys and pancreas, in animal models (Briffa et al., 2015).
Placental leptin may therefore also play a role in stimulating
organogenesis.
The motifs of two transcription factors, CBX3 and BCL6, were
significantly overrepresented, indicating involvement of these
transcription factor networks in the differential regulation of
trophoblast migration, proliferation and fusion following onset of
maternal blood flow. Aberrant expression of both transcription
factors has been reported in many types of cancer (Polo et al., 2007;
Zhao et al., 2019). It is possible there is an interaction between the
two transcription factor networks that regulates trophoblast
Fig. 6. Cluster analysis of biological process GO terms. To summarise the significant GO terms related to biological processes of the differentially
expressed genes between the first- and second-trimester groups, we performed a semantic similarity. Clusters of terms signify their biological relatedness.
Main clusters emerge for transmembrane transporters, cell differentiation and development, and leukocyte and adaptive immune response.
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migration, proliferation and fusion following the onset of maternal
blood flow. Supporting this notion is the fact that CBX3 is one of the
target genes of the repressor gene BCL6 (Polo et al., 2007). In
addition, cyclin dependent kinase inhibitor 1A (CDKN1A) is a
target of CBX3 (Zhao et al., 2019) and is downregulated in the
second trimester. CBX3 is known to be involved in transcriptional
silencing in heterochromatin-like complexes. There are several
differentially regulated growth regulating factors with CBX3 motif,
including SCML4 (protein coding gene, downregulated in the
second trimester), PRDM6 and 8 (histone methyltransferases),
ZBTB16 (transcription repressor) and PRKCB (all upregulated in
the second trimester).
Overall, the large number of differentially expressed genes (3260)
identified demonstrates the extensive transcriptome changes
occurring during the transition from first to second trimester,
spanning the onset of maternal blood-flow. As summarised in
Fig. 6, the key GO-term biological processes cluster by biological
similarity into clusters for transmembrane transporters, cell
differentiation and development, and leukocyte and adaptive
immune response reflecting the extensive changes the placental
must undergo with the switch from histotrophic to hemotrophic
nutrition.
Our study has a number of strengths that limit potential
confounding factors. Firstly, the placental samples were obtained
using a CVS technique and frozen immediately, avoiding the
activation of the stress response and HIF pathways when first-
trimester placental villi are collected using suction curettage and
exposed to maternal blood (Cindrova-Davies et al., 2015).
Secondly, gestational age was accurately assessed by
ultrasonography prior to the CVS procedure. Thirdly, the samples
were taken from narrow windows of gestation prior to and following
onset of the maternal circulation. The precise timing of onset in an
individual pregnancy is not known, but the intraplacental oxygen
concentration appears stable before 10 weeks and after 12 weeks of
gestation (Jauniaux et al., 2000). Onset is also a progressive
phenomenon, starting in the peripheral region of the early placenta
where it stimulates villous regression and moving centripetally
(Jauniaux et al., 2003b). Tissue effects are likely to be
heterogeneous during the transition period, but our samples were
all obtained from a consistent site, the central region of the placenta
identified under ultrasound guidance, limiting regional variability.
Finally, the RNA-Seq and methylation analyses were performed on
the same samples.
The rigorous collection protocol meant, however, that sample
sizes were relatively small. Nonetheless, some of the most DEGs
identified, such as those for the various hCG and hemoglobin loci,
were consistent with previous reports. In addition, we confirmed
many of the novel findings, such as for PKLR, spexin, musculin and
the meprins, at the protein level with immunohistochemistry. Our
sample groups were also biased towards males. Hence, we
performed a sex-adjustment analysis at the outset. The
differentially expressed genes identified in this study did not
intersect with those identified by Gong et al. (2018b), indicating that
sex-specific effects were unlikely to drive the first–second trimester
gene-expression differences observed.
The transcriptome can only provide an indication of potential
protein levels and function due to differential translation and post-
translational modifications. Nonetheless, it is clear that the
transition between the first and second trimesters is associated
with major physiological and morphological changes in the
placenta. Villous regression over the superficial pole of the
gestational sac leads to formation of the membranes and the
definitive placenta, and there is a loss of stemness and proliferation
of the villous cytotrophoblast cells (Burton et al., 2020). Premature
onset of blood flow occurs in many patients with first-trimester
miscarriage, suggesting that a failure to adapt successfully to the
environmental changes may trigger pregnancy loss or subsequent
complications (Jauniaux et al., 2003a). Our findings indicate that
DNAmethylation changes are part of the placental response to these
major environmental changes and may explain the altered DNA
methylation profiles seen in placentas from pregnancies
complicated by fetal growth restriction (Hillman et al., 2015).
Whether these changes are purely ontological or responsive to the
change in oxygenation, the loss of growth factor support from the
histotroph, or to increases in biomechanical stimuli requires further
research.
The unique nature of the first–second trimester transition during
human pregnancy may explain the high incidence of complications
of pregnancy in our species. In other mammals, histotrophic and
hemotrophic exchanges occur in separate areas of the extra-
embryonic membranes, such as the inverted yolk sac and the
chorioallantoic placenta of the mouse, respectively. In these species,
the placenta develops in a more consistent oxygen environment, and
the switch in nutrient pathways within the same tissue does not
occur. The situation in the human reflects our invasive interstitial
form of implantation, which is restricted to the great apes and for
which the evolutionary advantage is yet to be identified.
MATERIALS AND METHODS
Human tissue collection
First- and second-trimester tissue samples were collected with informed
written patient consent and approval of the Joint UCL / UCLH Committees
on the Ethics of Human Research (05/Q0505/82) from uncomplicated
pregnancies at 7–8 (n=8) and 13–14 weeks of gestation (n=6). Gestational
age was confirmed by ultrasound measurement of the crown–rump length
(CRL) immediately before the procedure. All samples were collected from
patients undergoing surgical pregnancy termination under general
anaesthesia for psychosocial reasons. Villous samples were obtained
under transabdominal ultrasound guidance from the central region of the
placenta using a chorionic villus sampling (CVS) technique. All samples
were snap-frozen immediately in liquid nitrogen and stored at -80°C until
analysis.
RNA extraction and RNA-Seq
RNA was extracted from human first-trimester placental villi using the
RNeasy Plus Universal Mini Kit (catalogue number 73,404; Qiagen).
Libraries were made using the Illumina TruSeq Stranded mRNA Library Kit
according to the manufacturer’s instructions. Libraries were quantified
(kappa qPCR), and equimolar pools were sequenced (paired end 100 base
reads, PE100) in several lanes of the Illumina NextSeq.
Bioinformatics
RNA-Seq analysis
Paired-end sequencing was performed on Illumina NextSeq Direct High
Output with read lengths of 100 bp. QC of sequencing was assessed using
FastQC (v 0.11.5), fastq_screen (v0.9.3) and Picard Tools (v 2.9.0) and
summarised with MultiQC (v1.8dev). Reads were trimmed to remove
adapters and low quality bases with TrimGalore! (v0.6.4) and aligned to the
human genome (GRCh38) with STAR aligner (v2.5.1b), with a mean of
90.4% reads uniquely mapping and mean of 56 M paired reads/sample.
Gene quantification was determined with HTSeq-Counts (v0.6.1p1).
Additional quality control was performed with a custom rRNA and
mtRNA counts script (provided on GitHub). Counts extracted with htseq-
counts were used to perform differential gene analysis in R (version 3.5.2)
using package DESeq2 (v.1.22.2). Sex of the samples was assigned using
sex-specific gene expression Xist, Rps4y1, Ddx3y, Usp9y and Sry and was
included in the design formula (∼ sex+condition) as a blocking factor to
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account for variation in the data. Additionally, DEG list was compared with
the list of genes expressed differentially in placenta depending on fetal sex
(Gong et al., 2018a). Among our list of 3242 genes (with fold change>2),
there were none overlapping with the list (101 genes). Read counts were
normalised on estimated size factors. Principal component analysis (PCA)
was performed on rlog-transformed count data for all genes. GO and Kegg
pathway analysis were performed using clusterProfiler package (v.3.10.1)
on DEGs with absolute log2 fold change >1 and adjusted P value <0.05
were used. Kegg pathway analysis was performed for upregulated and
downregulated genes separately. The data matrix for scRNA-seq data were
obtained from the Wang lab (16) (GEO accession number GSE89497).
Regularised log transformation function (fromDESeq2 package) was applied
to counts for heatmaps. Heatmaps were generated with ‘ComplexHeatmap’ R
package (v 1.20.0). Selection of differentially expressed genes on heatmaps
was based on highest significance (lowest adjusted P value) and highest
absolute log2 fold changes. To investigate potential regulatory networks of
the placenta, RcisTarget R package was used (v.1.2.1). Motif rankings for tss-
centered-10 kb and 500 bp upstream of TSSwere used in the analysis (human
motif collection version 9, ‘mc9nr’, with 24453 motifs). DEGs were scanned
for the motifs and DNA motifs significantly over-represented in a gene-set
were identified. DEGs with enriched motifs were analysed with enrichR r
package (v.1.0) for pathway enrichment. Semantic similarity of GO terms was
performed with the rrvigo R package (v1.2.0), using significant Biological
Process GO terms.
Integration of RNA-Seq with single cell RNA-Seq (scRNA-Seq)
The GSE89497 scRNA-Seq dataset downloaded as a matrix processed as
described in Liu et al. (2018). The matrix was normalized and scaled in
Seurat (Stuart et al., 2019) for use in the heatmaps.
DNA Methylation analysis
Infinium methylationEPIC array
In order to compare the sequencing andmethylation changes in the placenta,
we extracted the DNA from the same patient samples, as those used for RNA
extraction. Genomic DNAwas isolated by QIAamp DNA mini kit (Qiagen,
catalogue number 51304) following the manufacturer’s instructions. Buffer
AL (200 μl) was added to the sample, mixed by pulse-vortexing for 15 s,
before incubating at 70°C for 10 min. Absolute Ethanol (200 μl) was then
added to the sample, and mixed by pulse-vortexing for 15 s before
transferring to the QIAamp Mini spin column and centrifuged at 6000 g for
1 min. The Mini spin column was washed once with Buffer AW1 (500 μl)
following by Buffer AW2 (500 μl) before centrifuging at full speed for
1 min. For elution of genomic DNA, DNase-free water (100 μl) was added
and incubated for 1 min before centrifuging at 6000 g for 1 min. The step
repeated one more time with another 100 μl DNase-free water. DNA
concentration of the samples were quantified by NanoDrop and the DNA
quality was checked by resolving in 0.8% agarose gel, in which there was a
major band visualised at around 10 kbp without obvious smear below,
indicating good quality DNA.
Genomic DNA oxidative bisulfite (oxBS) conversion was performed
using the CEGX TrueMethyl kit (Cambridge Epigenetix/NuGEN, cat. no.
CEGXTMS) and used for microarray-based DNA methylation analysis,
performed at GenomeScan (GenomeScan B.V., Leiden, The Netherlands)
on the HumanMethylation850 BeadChip (Illumina, Inc., San Diego, CA,
USA). The EPIC array interrogates approximately 865,000 CpG sites
representing about 99% of the RefSeq genes. The resulting iDAT files were
imported and analysed using ChAMP (v2.9.10) (Aryee et al., 2014; Morris
et al., 2014). Samples were processed filtering for a probe detection P
value≤0.01, probes with a beadcount <3 in at least 5% of samples, no CpG
and known SNPs (Zhou et al., 2017) at probe starts, probes aligning to
multiple locations, and QC using the on array control probes. In total,
750150 probes on the array passed the filtering and QC steps. The BMIQ
(Teschendorff et al., 2013) method was used to normalise the two probe
types (I and II) present on the array. Beta methylation values from the EPIC
array range from 0 (unmethylated) to 1 (methylated) and are equivalent of
percentage methylation.
To account for sex specific differences we performed batch correction
with champ.runCombat, using sex as the variable for correction. The PCA
plot was generated for the top 500 most variably methylated CpGs. DMRs
were calculated using the bumpHunter methods in ChAMP, and a
methylation difference of 0.2 and adjusted P value of 0.05 between first
and second trimesters was used for filtering DMRs. A threshold of 0.2
(20%) was used to select methylation differences above the cell-type
variation within the placenta samples. A 20% threshold has been chosen in
veriaous studies including in autoimmune disease (Lanata et al., 2018),
CRISPR screens (Farris et al., 2020) and cancer (Dominguez et al., 2015).
Probes on the X and Y chromosomes were excluded to minimise sex
specific in differential methylation calculations. Pearson’s correlation (R
function cor.test) was used to calculate P values between DMRmethylation
and differential gene expression was calculated Pearson’s. Bedtools
(Quinlan and Hall, 2010) was used to determine DMRs overlapping gene
bodies and promoters (bedtools closest -D b -d) -a DMRs.bed -b
GRCh37.87.gtf.bed and 1.5Kb upstream of the TSS used to define
promoters). GO analysis on for DMRs in gene bodies and promoters was
performed with ‘goregions’ from missMethyl (Phipson et al., 2016).
Multiple DMRs per gene were manually checked and in all cases the
methylation change was in the same direction. Where a DMR overlapped
two genes, both were included in the correlation with gene expression. A list
of the top 100 DMRs associated with sex-specific methylation in human
placentas are from Gong et al. (2018a). An intersection of sex-specific
DMRs with the identified DMRs with associated expression changes above
thresholds (log2 FC 1, methylation difference 0.2) show no common genes,
suggesting the identified DMRs are not sex-specific.
Data and code availability
RNA-Seq
Scripts used can be found on GitHub (https://github.com/CTR-BFX/2020_
Prater_Cindrova). RNA-sequencing data is accessible through the EMBL-
EBI ArrayExpress accession number: E-MTAB-9203. http://www.ebi.ac.
uk/arrayexpress/experiments/E-MTAB-9203.
DNA Methylation (EPIC Array)
Code used to analyse the EPIC array samples is available on GitHub
(https://github.com/CTR-BFX/First-Second-Trimester-Methylation). EPIC
methylation array data have been deposited at EMBL-EBI ArrayExpress
under accession number E-MTAB-9312 (https://www.ebi.ac.uk/
arrayexpress/experiments/E-MTAB-9312).
Immunohistochemistry
Immunohistochemistry was performed as previously described (Cindrova-
Davies et al., 2007) using the following primary antibodies: anti-XBP1
(ab109621, Abcam), anti-phospho-IRE1 (ab48187, Abcam), anti-IRE1
(ab37073, Abcam), anti-ATF6 (ab37149, Abcam), anti-pyruvate kinase L/R
(PB9499, Boster), anti-spexin (H-023-81, Phoenix Pharmaceuticals), anti-
MEP1α (ab232892, Abcam), anti-CD31 (M0823, Dako), anti-musculin
(ab64954, Abcam). Negative controls were performed by replacing primary
antibodies with the blocking serum.
Western blotting
Placental lysates were processed and run on western blots, as previously
described (Cindrova-Davies et al., 2007), using the following antibodies:
anti-TTR (PA5-80197, Thermo Fisher Scientific), anti-leptin (ab2125,
Abcam), anti-ApoA1 (PA5-78798, Thermo Fisher Scientific), anti-eIF2α
(#3398, Cell Signaling), anti-GRP78 (610978, Transduction Laboratories),
anti-GPX1 (ab167989, Abcam).
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